Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

A randomized trial comparing the platinum-chromium everolimus-eluting stent to the cobalt-chromium everolimus-eluting stent in 2980 all-comers patients undergoing PCI, finding the platinum-chromium stent noninferior for target vessel failure at 1 year.

PDF) A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

Percutaneous coronary intervention using a combination of robotics and telecommunications by an operator in a separate physical location from the patient: an early exploration into the feasibility of telestenting (the REMOTE-PCI study)

Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial

Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience

Left bundle branch block after sutureless, transcatheter, and stented biological aortic valve replacement for aortic stenosis

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

Left bundle branch block after sutureless, transcatheter, and stented biological aortic valve replacement for aortic stenosis

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation

Percutaneous coronary intervention using a combination of robotics and telecommunications by an operator in a separate physical location from the patient: an early exploration into the feasibility of telestenting (the REMOTE-PCI study)

The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre